Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.

2024
Pharmaceuticals

Therapeutic Area

Glaucoma
Categories

Other

Affiliations

Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd., Nara, 630-0101, Japan; Ophthalmology Innovation Center, Santen Inc., Emeryville, 94608, CA, United States; Institute of Ophthalmology, University College London, London, WC1E 6BT, United Kingdom; Imperial College of Science and Technology, St. Mary’s Campus, London, SW7 2AZ, United Kingdom; Eye-APC Duke-NUS Medical School, Singapore, 169857, Singapore; Department of Pharmacy Sciences, Creighton University, Omaha, 68178, NE, United States; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, 77004, TX, United States; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, 76107, TX, United States; Singapore Eye Research Institute, Singapore, 169856, Singapore; Global Research and Development, Nanoscope Therapeutics Inc., Dallas, 75207, TX, United States; EyeCRO LLC, Oklahoma City, 73105, OK, United States

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.

Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.